No abstract available
MeSH terms
-
Age Factors
-
Benchmarking
-
Cystic Fibrosis / diagnosis*
-
Cystic Fibrosis / mortality
-
Cystic Fibrosis / therapy
-
Early Diagnosis
-
Evidence-Based Medicine
-
Humans
-
Infant, Newborn
-
Longevity
-
Neonatal Screening / adverse effects
-
Neonatal Screening / organization & administration*
-
Patient Selection
-
Practice Guidelines as Topic
-
Risk Factors
-
Survival Rate
-
Total Quality Management / organization & administration
-
Treatment Outcome